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Mast cells (MCs) are powerful immune cells that mature in the peripheral tissues from 
bone marrow (BM)-derived mast cell progenitors (MCp). Accumulation of MCs in lung 
compartments where they are normally absent is thought to enhance symptoms in 
asthma. The enrichment of lung MCs is also observed in mice subjected to models of 
allergic airway inflammation. However, whether other types of lung inflammation trigger 
increased number of MCp, which give rise to MCs, is unknown. Here, mouse-adapted 
H1N1 influenza A was used as a model of respiratory virus infection. Intranasal administra-
tion of the virus induced expression of VCAM-1 on the lung vascular endothelium and an 
extensive increase in integrin β7hi lung MCp. Experiments were performed to distinguish 
whether the influenza-induced increase in the number of lung MCp was triggered mainly 
by recruitment or in situ cell proliferation. A similar proportion of lung MCp from influenza- 
infected and PBS control mice were found to be in a proliferative state. Furthermore, 
BM chimeric mice were used in which the possibility of influenza-induced in  situ cell 
proliferation of host MCp was prevented. Influenza infection in the chimeric mice induced 
a similar number of lung MCp as in normal mice. These experiments demonstrated that 
recruitment of MCp to the lung is the major mechanism behind the influenza-induced 
increase in lung MCp. Fifteen days post-infection, the influenza infection had elicited 
an immature MC population expressing intermediate levels of integrin β7, which was 
absent in controls. At the same time point, an increased number of toluidine blue+ 
MCs was detected in the upper central airways. When the inflammation was resolved, 
the MCs that accumulated in the lung upon influenza infection were gradually lost. In 
summary, our study reveals that influenza infection induces a transient accumulation of 
lung MCs through the recruitment and maturation of MCp. We speculate that temporary 
augmented numbers of lung MCs are a cause behind virus-induced exacerbations of 
MC-related lung diseases such as asthma.
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inTrODUcTiOn
Mast cells (MCs) develop from committed mast cell progenitors 
(MCp) in the bone marrow (BM), which enter tissues via the 
blood and mature into MCs (1). These cells play a crucial role 
in life-threatening allergic reactions such as in anaphylaxis and 
asthma attacks. In patients with asthma, MCs accumulate in the 
airway smooth muscles and lung epithelium (2, 3). The increase 
in MC numbers, particularly at these places in the lung, likely 
worsens the symptoms of the disease. Respiratory virus infections 
are the major cause of exacerbations of asthma (4). The exacerba-
tions lead to suffering for the patients, and in worse case, they can 
have a fatal outcome.
Influenza infection is one of the most common respiratory 
virus infections associated with acute asthma exacerbations. This 
was especially studied during influenza A H1N1 worldwide out-
break in 2009, when asthma was one of the most common under-
lying medical conditions among hospitalized patients (5). MCs 
may play a role in influenza infections through their activation 
by pattern recognition receptors (6). In fact, mice lacking MCs 
(B6.Cg-kitW-sh) are protected from excessive inflammation fol-
lowing influenza A infection (7). Moreover, Graham et al. dem-
onstrated that MCs can be activated by influenza virus in vitro 
to produce cytokines and that this process was dependent on 
activation of the pattern recognition receptor RIG-I. Therefore, 
MCs may contribute to the pathology associated with influenza 
infections.
We have previously studied the mechanisms behind the 
massive recruitment of MCp to the lung, which occurs in an 
experimental asthma model in mice (8–12). The influx of MCp 
to the lung, which is dependent on VCAM-1 on the lung vascular 
endothelium and the expression of α4-integrins on the MCp (8), 
was followed by an increase in mature MCs in the lung (9, 12, 13). 
Interestingly, VCAM-1 transcripts in the lungs of mice are 
upregulated from 2 to 8 days after influenza infection (14). This 
indicates that MCp may be recruited in a VCAM-1-dependent 
manner upon influenza infection. Thus, we hypothesized that 
influenza infection can amplify the number of lung MCs through 
the accumulation of MCp. These MC lineage-committed progeni-
tors in adult mice were originally identified in the BM (15, 16) 
and intestine (17). However, we demonstrated that MCp can be 
detected in mouse blood as lineage− (Lin−) c-kithi T1/ST2+ inte-
grin β7hi CD16/32hi cells (18). The majority of the blood MCp in 
the BALB/c strain express FcεRI (66%), whereas only a minority 
(25%) of blood MCp in the C57BL/6 strain are positive for this 
marker (18). In the periphery such as in the peritoneum and 
lungs, virtually all of the MCp express FcεRI (19). Hence, in the 
lungs of naïve mice, there are two MC populations that can be 
detected by flow cytometry, mature MCs with high side scatter 
(SSC) properties which lack or have low expression of integrin β7 
and the MCp population that express high levels of integrin β7 
and have lower SSC properties (19). Similarly, the maturity of lung 
MCs can be distinguished by SSC and expression level of integrin 
β7 in mice subjected to allergic pulmonary inflammation (13).
In this study, we tested whether influenza infection in mice 
could stimulate an increase in lung MCp. A laboratory virus 
strain, the H1N1 influenza A/PR/8/34 virus (PR8), was used. 
Since an enhanced number of MCp in the lung after influenza 
infection can be a result of either induced recruitment or in situ 
proliferation, several types of experiments were performed to 
distinguish between these mechanisms. Intranasal administra-
tion of PR8 induced recruitment of highly proliferating MCp to 
the lung. Fifteen days post-infection, while MCp were still the 
most frequent MC type in the lung, an immature MC population 
expressing intermediate levels of integrin β7 was detected by 
flow cytometry. At this time point, influenza-induced toluidine 
blue+ MCs were found in association with the inflammatory cells 
surrounding bronchioles (Br) in the upper central airways. They 
also frequently appeared in the perivascular region and even in 
or close to endothelial and epithelial cells. When the lung inflam-
mation was resolved, the majority of the MCs that appeared after 
influenza infection were gradually lost, likely due to homeostatic 
mechanisms. Therefore, we conclude that influenza infection in 
mice induces a transient accumulation of MCs in the lung, which 
mainly occur through recruitment and maturation of MCp.
MaTerials anD MeThODs
animals
Age- and sex-matched mice were bred and housed in the animal 
facility at the National Veterinary Institute (SVA), Uppsala, 
Sweden. All mice were at least 6  weeks old when they were 
used for experiments. Wild-type BALB/c mice were originally 
obtained from Bommice (Ry, Denmark). CD45.1 congenic mice 
on BALB/c background were purchased from Jackson Laboratory 
(Bar Harbor, ME, USA) and subsequently bred in-house. This 
study was carried out in accordance with the recommendations 
of Jordbruksverket. The protocol was approved by Uppsala 
Djurförsöksetiska nämnd, Stockholms Norra Djurförsöksetiska 
nämnd, or Stockholms Djurförsöksetiska nämnd.
influenza a Virus infection Protocol
Isoflurane-anesthetized mice were inoculated intranasally with 
3–5 × 104 TCID50 of the H1N1 influenza A/Puerto Rico/8/34 strain 
or given an equal volume of PBS. Influenza virus was propagated 
in embryonated hen’s eggs, and strain purity was confirmed by 
PCR as previously described (20). Mice were weighted just before 
infection or PBS treatment (day 0). Weight loss was monitored on 
all mice during the course of the experiment. Mice that lost ≥15% 
of their initial body weight (weight at day 0) before the planned 
termination day were euthanized and excluded from the study.
extraction of lung cells
The blood was removed from the lungs by injection of 10  ml 
PBS into the right ventricle of the heart. For results shown in 
Figure 1, lungs were minced with scalpels followed by enzymatic 
degradation of tissue by collagenase type IV (150  U/ml) (Life 
Technologies, Paisley, Scotland, UK) as previously described 
(12). In all other experiments, the lungs were mechanically and 
enzymatically dissociated into single-cell suspensions using the 
gentleMACS Octo Dissociator and mouse lung dissociation kit 
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to the 
manufacturer’s instructions. The released lung cells were either 
FigUre 1 | infection with Pr8 influenza a virus increases the number of lung Mcp. Wild-type mice were infected with 3–5 × 104 TCID50 PR8 influenza virus 
or instilled with PBS intranasally. Ten days post-infection, (a) lung mononuclear cells (MNC) were isolated and quantified by manual counting on a hemocytometer 
and (B) the frequency of MCp/106 MNC and (c) the total number of MCp per mouse lung were determined using a limiting dilution and clonal expansion assay. The 
graphs in panels (a–c) show 6–10 individual mice per group pooled from 3 independent experiments. (D) The body weight was monitored during the course of the 
experiment. The data are normalized to each mouse’s initial body weight (weight at day 0). (a–D) All data are presented as mean ± SEM. (e) Representative pictures 
from H&E-stained lung tissue sections from PBS controls or PR8-infected mice 10 days post-infection. The black arrows point to the inflammatory cells that 
extravasated into the airway lumen or were associated with blood vessels (Bv). The inflammatory cells also frequently surrounded the bronchioles (Br). Ad, alveolar 
ducts; As, alveolar sacs (***P < 0.001).
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enriched for mononuclear cells (MNC) using Percoll (Sigma-
Aldrich, St. Louis, MO, USA) gradient centrifugation as described 
previously (12) or resuspended in 44% Percoll to remove the 
tissue residues and subsequently treated with red blood cell lysis 
buffer (150 mM NH4Cl, 9.5 mM NaHCO3, 1.2 mM EDTA). After 
purification, the viable cells were counted on a hemocytometer 
using trypan blue exclusion.
Quantification of lung Mc Populations
A limiting dilution and clonal expansion assay (21) was carried 
out to quantify lung MCp in Figure 1. Briefly, lung MNC were 
cultured at eight different cell concentrations with IL-3, stem cell 
factor (SCF), and feeder cells in 96-well plates. After 12–14 days, 
the wells were scored as positive or negative for MC colony 
growth. The frequency of MCp/MNC was estimated using the 
Poisson distribution.
In the remaining figures, the frequency of lung MCp and 
mature MCs were quantified by flow cytometry. Lung MNC 
or whole lung cells were stained with the following monoclo-
nal antibodies: Alexa Flour 700-conjugated CD45 (30-F11), 
PE-Cy7-conjugated c-kit (2B8), PE-conjugated FcεRIα (MAR-1), 
FITC-conjugated integrin β7 (FIB504), Brilliant Violet 605-con-
jugated CD16/32 (2.4G2), PE-Cy5-conjugated lineage antibodies 
to CD3 (17A2), CD4 (GK1.5), CD8b (eBioH35-17.2), CD11b 
(M1/70), CD19 (ebio1D3), Gr-1 (RB6-8C5), B220 (RA3-6B2), 
TER-119 (TER-119), and Brilliant Violet 421-conjugated 
T1/ST2 (DIH9) or biotinylated T1/ST2 (DJ8) followed by incu-
bation with streptavidin-APC. Fluorescence minus one (FMO) 
controls with the appropriate isotype antibody were used. For 
detection of isoform-specific CD45, isolated MNC were stained 
with Brilliant Violet 421-conjugated CD45.1 (A20) and Alexa 
Flour 700-conjugated CD45.2 (104) antibodies instead of the 
general CD45 antibody. FMO controls were used to gate CD45.1+ 
and CD45.2+ MCp populations. To determine the percentage 
of proliferating (Ki-67+) MCp, isolated lung MNC were first 
stained with antibodies directed to surface markers. After fixa-
tion and permeabilization using the Foxp3/transcription factor 
staining buffer set (eBioscience, San Diego, CA, USA), the cells 
were blocked with 2% normal mouse serum followed by stain-
ing with Ki-67-PE (B56). A FMO control with the appropriate 
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isotype antibody was used. The MCp were identified as CD45+  
Lin−/lo c-kithi T1/ST2+ CD16/32int integrin β7hi cells. The antibod-
ies were from BD Biosciences (Franklin Lakes, NJ, USA), eBiosci-
ence (Hatfield, UK), or MD Bioproducts (Zürich, Switzerland). 
Stained cells were analyzed on a LSR II, LSR Fortessa flow 
cytometer, or FACS aria III (BD Biosciences), and data analysis 
was performed using the FlowJo software (TreeStar Inc., Ashland, 
OR, USA). In all flow cytometry analyses, doublet cells and debris 
were excluded. The total cell numbers from the quantifications 
are presented as the cell number/mouse lung. Mouse lung refers 
to all five lung lobes from a single mouse.
Detection of In Situ Proliferation Using 
BrdU
Seven days after intranasal delivery of PR8 or PBS, all mice were 
lightly anesthetized by isoflurane inhalation and administered 
16 mg/ml BrdU (0.8 mg/mouse) intranasally. The next day, mice 
were euthanized, the blood was removed, and the lungs were col-
lected. After digestion of the lung tissue as described earlier, the 
lung cells were resuspended in 44% Percoll to remove the tissue 
residues. Thereafter, the lung cells were treated with red blood cell 
lysis buffer, stained with fluorescently labeled antibodies, fixated, 
and permeabilized as described for Ki-67. After intracellular 
staining with Brilliant Violet 510-conjugated anti-BrdU antibod-
ies (3D4, BD Biosciences), the cells were analyzed on the LSR 
Fortessa flow cytometer. A FMO control with the appropriate 
isotype antibody was used to determine the gate for the BrdU+ 
cells.
generation of BM chimeras
Bone marrow cells were isolated from femur and tibia of CD45.1 
mice by flushing the bones using PBS. The cells from whole BM 
were counted on a hemocytometer using trypan blue dye, dem-
onstrating a high degree of viable cells. The BM cells were injected 
intravenously (15 × 106 cells per mouse) into γ-irradiated (5 Gy) 
BALB/c (CD45.2) mice. Two days later, mice were infected with 
PR8 or given PBS intranasally.
histological and immunofluorescence 
analyses
Lungs were removed and filled with 1.5 ml of OCT embedding 
media (Sakura Finetek, Alphenaan den Riijn, The Netherlands) 
diluted 1:1 with PBS, covered with OCT embedding media, and 
directly frozen in liquid nitrogen. The tissue was stored at −80°C 
until the section process. Eight-micrometer sections were cut 
with a cryostat and mounted on Menzel-Gläser Superfrost slides 
(Thermo Scientific, Braunschweing, Germany), air dried, and 
stored at −20°C until staining. To analyze the cellular infiltrates 
from day 10 post-infection, tissue sections were stained with 
hematoxylin and eosin (Histolab Products AB, Gothenburg, 
Sweden). To quantify the number of MCs, sections were stained 
with toluidine blue 1% and counter-stained with hematoxylin. 
The number of toluidine blue+ cells per slide was quantified in 
a blinded fashion using 20× magnification. The central airways 
were identified as airways proximal to the trachea branch in the 
upper lobes and the small airways were those with a small diam-
eter, associated with the presence of alveolar sacs and respiratory 
bronchioles.
For immunostaining, slides were fixed in chilled 100% acetone 
(−20°C). After washing in PBS (pH 7.8), the slides were blocked 
with 5% horse serum (Sigma-Aldrich) in PBS for 30  min. The 
slides were stained with LEAF Purified anti-mouse CD106/
VCAM-1 (BioLegend, San Diego, CA, USA) 1.5  μg/ml in 5% 
horse serum for 1 h. After washing twice in PBS, the slides were 
incubated with goat anti-rat Alexa Flour 594 (Life Technologies) 
1  μg/ml in 5% horse serum for 1  h. After washing twice in 
PBS, the slides were mounted in DAPI (prolong Gold Antifade 
Mountant with DAPI, Life Technologies). The immunostained 
slides were analyzed with a LSM 700 confocal microscope (Carl 
Zeiss, Thornwood, NY, USA). At least five images from each 
section were taken, using Zen 2009 software (Carl Zeiss), and 
analyzed with ImageJ software (http://rsb.info.nih.gov/ij/) (NIH, 
Bethesda, MD, USA). The intensity per field was calculated in the 
Alexa Flour 594 channel and was reported as positive signal per 
field (raw integrated density − mean raw intensity of background 
readings). The fluorescence of background readings was taken 
in three regions next to the positive area in each image, and the 
average was used for the subtractions.
statistical analysis
Statistical differences between groups were assessed using 
unpaired, two-tailed Student’s t-test for Figures 1, 3F,G, 4 and 
5B. For Figures 2 and 3B,D, one-way ANOVA with Dunnett’s test 
for pairwise comparison was performed to determine the statisti-
cal significance. For Figure 2, the data were log-transformed to 
compensate for unequal variation between the control group and 
the treatment groups before performing the statistical analysis. In 
Figures 5D and 6, all groups were compared to each other, and 
therefore, the statistical significance was determined by one-way 
ANOVA with post  hoc Tukey’s test. All graphs were prepared 
and statistics calculated using GraphPad Prism 5.0c (GraphPad 
software Inc., San Diego, CA, USA). A p-value of less than 0.05 
was considered significant.
resUlTs
influenza infection stimulates a Massive 
increase in the number of lung Mcp
MCs accumulate in the lung of asthmatics and in mice subjected 
to experimental models of allergic pulmonary inflammation. 
In such models, the MC accumulation is preceded by recruit-
ment of MCp to the lung (1). However, whether other types of 
stimuli of the lung such as influenza infection can trigger a similar 
type of response has remained unknown.
Wild-type BALB/c mice were given PBS or a sublethal dose 
of PR8 virus intranasally. This virus causes respiratory disease 
that can be monitored by weight loss. Ten days post-infection, 
the yield of lung MNC increased around 9 times in PR8-infected 
mice as compared with PBS-treated mice (Figure 1A). On the 
same day, the frequency of lung MCp was approximately 5 times 
higher in PR8-infected mice (Figure 1B), and the total number 
FigUre 2 | Pr8 infection stimulates an increase in lung Mcp that starts on day 4 post-infection. Wild-type mice were infected with 4 × 104 TCID50 PR8 
influenza virus and euthanized at the indicated days post-infection. Non-infected (NI) naïve mice were analyzed in parallel for comparison. (a) Representative gating 
strategy used for identification of lung MCp (the sample shown is from 10 days post-infection). MCp were identified as CD45+ Lin−/lo c-kithi T1/ST2+ FcεRI+ 
CD16/32int integrin β7hi cells. (B) The number of mononuclear cells (MNC) per lung. (c) The frequency of the MCp was calculated by dividing the number of gated 
CD45+ Lin−/lo c-kithi T1/ST2+ FcεRI+ CD16/32int integrin β7hi cells with the number of all MNC (pre-gated on singlet cells and debris excluded) and expressed as 
MCp/106 MNC. (D) The total number of lung MCp was calculated for each mouse. The bars show the mean ± SEM of 6–14 individual mice per group pooled from 
2 to 3 individual experiments, except for the NI, which is pooled data from 5 experiments in total (*P < 0.05, **P < 0.01, ***P < 0.001).
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of lung MCp per mouse was around 28 times higher than in PBS 
control mice (Figure 1C), as evaluated by a limiting dilution and 
clonal expansion assay (21). Ten days post-infection, the PR8-
infected mice had lost on average 10% of their initial body weight 
(weight at day 0) (Figure 1D). At this time point, inflammatory 
cells had accumulated around bronchioles and blood vessels in 
the lungs (Figure  1E, left and middle panels) and pneumonia 
could be detected (Figure 1E, right panel).
influenza infection induces a Time-
Dependent increase in lung Mcp
A flow cytometry approach was used to investigate the kinetics of 
the PR8-induced increase in lung MCp. Lung MCp were identified 
as CD45+ Lin−/lo c-kithi T1/ST2+ FcεRI+ CD16/32int integrin β7hi 
cells, similar to what we previously described (19) (Figure 2A). 
The PR8-induced increase in lung MCp was followed over a course 
of 10  days post-infection. On average, a significant increase in 
MNC as well as in the frequency and total number of lung MCp 
per mouse was detected 4 days post-infection (Figures 2B–D). 
However, on days 4 and 5, there is a large variation in the frequency 
of MCp between the PR8-infected mice, i.e. some of the individual 
mice have a higher MCp frequency in the lung than PBS control 
mice, and some do not. From 6 days post-infection and beyond, 
there was a robust increase in the frequency and total number 
of lung MCp per mouse (Figures 2C,D). Remarkably, at day 10 
post-infection, the total number of lung MCp per mouse was 
approximately 29 times higher than in naïve mice (Figure 2D). 
The PR8-induced fold increase in total lung MCp quantified by 
flow cytometry was at a similar level as the fold increase detected 
by the limiting dilution assay (compare Figure 2D to Figure 1C).
a similar Proportion of lung Mcp from 
Pr8-infected and naïve or PBs control 
Mice are in a Proliferative state
The increase in the frequency and number of lung MCp after 
PR8 infection could theoretically be explained by virus-induced 
stimulation of MCp cell division or recruitment of MCp from 
the blood to the lung. To determine whether the PR8 infection 
affected the proliferation state of lung MCp, the proportion of 
Ki-67+ MCp was assessed following the gating strategy shown 
in Figure 3A. Ki-67 is an intracellular protein expressed only in 
proliferating cells (22, 23). A FMO control with an appropriate 
mouse IgG1 isotype antibody added was used to determine the 
Ki-67+ proportion of the cells. The proportion of proliferating 
Ki-67+ MCp among total lung MCp was approximately 51% 
in naïve mice (Figure  3B). PR8 infection did not increase the 
proliferative state of the MCp (Figure 3B). However, in 1 out of 
the 6 experiments, there was a significantly higher percentage of 
Ki-67+ lung MCp 10 days post-infection than in naïve mice when 
analyzed by a Student’s t-test (60 ± 2 vs. 45 ± 4%).
FigUre 3 | a similar proportion of lung Mcp from Pr8-infected and naïve or PBs control mice are in a proliferative state. (a–D) Wild-type mice were 
infected with PR8 influenza virus and euthanized at the indicated days post-infection. Non-infected (NI) naïve mice were analyzed in parallel for comparison. (a,B) 
The isolated lung mononuclear cells were stained with antibodies recognizing the indicated surface markers followed by intracellular staining with an antibody 
against Ki-67. (a) CD45+ Lin−/lo c-kithi T1/ST2+ CD16/32int integrin β7hi lung MCp were analyzed for expression of Ki-67 following the illustrated gating strategy for a 
representative sample (the sample shown is from day 10 post-infection). (B) The percentage of Ki-67+ lung MCp in NI and PR8-infected mice at the indicated days 
post-infection. (c) CD45+ Lin+/hi c-kit− FSClo SSClo lung cells were analyzed for expression of Ki-67 following the illustrated gating strategy. (D) The percentage of 
Ki-67+ CD45+ Lin+/hi c-kit− FSClo SSClo lung cells in NI and PR8-infected mice at the indicated days post-infection. In panels (a,c), the open white histogram shows 
cells stained with mouse anti-Ki-67 antibody, whereas the solid gray histogram shows a fluorescence minus one (FMO) control with an appropriate mouse IgG1 
isotype antibody added. The graphs in panels (B,D) show the mean ± SEM of pooled data from 1–2 experiments for each individual day analyzed post-infection. 
The data represent 7–8 mice per group (days 5, 7, and 10 post-infection), 3–4 mice per group (days 2, 4, 6, and 8 post-infection), and 11 NI mice pooled from in 
total 6 experiments. (e–g) Seven days post-infection with PR8 influenza virus or installation of PBS, wild-type mice were given a single intranasal dose of BrdU. The 
next day, whole lung cells were analyzed for the presence of BrdU+ MCp. (e) Representative samples showing the gating for BrdU+ lung MCp, which was set using 
a FMO with the corresponding mouse IgG1 isotype control added. The mean ± SEM (F) percentage of BrdU+ lung MCp and (g) the geometric mean fluorescence 
intensity (gMFI) for the BrdU+ lung MCp from 9 mice per group pooled from 2 individual experiments are shown (***P < 0.001).
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Lymphocytes such as activated CD8+ T  cells continue to 
proliferate after their arrival to the lungs in influenza infection 
(24). Therefore, CD45+ Lin+/hi c-kit− forward scatter (FSC)lo SSClo 
lung cells, which likely consists of mostly lymphocytes, were 
gated for their proportion of Ki-67+ cells (Figure 3C). In naïve 
mice, 11% of the cells in the CD45+ Lin+/hi c-kit− FSClo SSClo gate 
were Ki-67+. Nevertheless, 10 days post-infection, the proportion 
of Ki-67+ CD45+ Lin+/hi c-kit− FSClo SSClo cells had increased up 
to 36% (Figure 3D). Taken together, these results indicate that 
MCp from naïve mice are in a high proliferative state that remains 
constant after PR8 infection.
A BrdU incorporation assay was used to verify the conclusions 
from the Ki-67 staining of lung MCp (Figures 3E–G). On day 7 
post-infection, a single intranasal installation of BrdU was given 
to mice infected with PR8 or treated with PBS. The following 
day, the percentage of BrdU+ MCp was determined (Figure 3E). 
A high percentage of lung MCp was BrdU+ in both groups of 
mice (Figures  3E,F). Following a similar gating strategy as in 
FigUre 4 | Pr8 infection induces upregulation of VcaM-1 expression 
on the lung vascular endothelium. Lungs from PR8-infected and PBS 
control mice were collected 6 days post-infection. Sections of lung tissue 
were stained with rat anti-mouse VCAM-1 antibody (red) and DAPI (blue).  
(a) Representative immunofluorescence staining of mouse lung tissue, 
original magnification 10×. (B) Quantification of VCAM-1 expression in lung 
tissue sections. The graphs show the quantification of VCAM-1 intensity/field 
from 5 sections per mouse. The data are pooled from 2 independent 
experiments with 7–8 individual mice per group. The bars show mean ± SEM 
(***P < 0.001).
FigUre 5 | Pr8 infection induces the recruitment of Mcp to the lung. 
(a) CD45.2 BALB/c mice were sublethally γ-irradiated with 5 Gy and 
reconstituted with bone marrow (BM) cells from CD45.1 BALB/c mice, 
2 days before infection (day 0). (B) The total number of lung MCp 2 days 
post γ-irradiation and BM transfer. The chimeric mice were either infected 
with PR8 or injected with PBS. Naïve non-irradiated CD45.2 mice were 
included as controls. (c,D) CD45.1+ MCp are represented in blue, while 
CD45.2+ MCp are represented in red. (c) Representative dot plots showing 
the CD45.1+ and CD45.2+ lung MCp populations. Fluorescence minus one 
controls were used to gate CD45.1+ and CD45.2+ MCp populations. (D) The 
total number of lung MCp 8 days post-infection. The graph in panel (B) show 
the mean ± SEM from 9–11 individual mice per group pooled from 4 
independent experiments. The graph in panel (D) show the mean ± SEM 
from 12–15 individual mice per group pooled from 3 independent 
experiments (**P < 0.01, ***P < 0.001).
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the lung, the CD45+ Lin−/lo c-kithi T1/ST2+ FcεRI+ CD16/32int 
integrin β7hi MCp-like cells in the BM were also to a high degree 
BrdU+, suggesting that BrdU had diffused to the BM (Figure S1 
in Supplementary Material). Although this prevents us from 
concluding that the BrdU positivity refers only to in situ cell divi-
sion in the lung, these experiments clearly show that MCp in the 
BM and lung are dividing. The lung MCp from the PR8-infected 
mice had lower geometric mean fluorescence intensity (gMFI) 
for BrdU than the lung MCp from PBS control mice (Figure 3G), 
indicating that on average, each dividing MCp in the PBS control 
mice had taken up more BrdU than the BrdU+ MCp from PR8-
infected mice. Collectively, the Ki-67 and BrdU data demonstrate 
that PR8 infection does not induce an increased cell proliferation 
of lung MCp.
influenza infection stimulates the 
recruitment of Mcp to the lung
Upon allergic airway inflammation, MCp are recruited to the 
inflamed lung in a process that is dependent on the expression 
of α4β1- and α4β7-integrins on the MCp and induced expres-
sion of VCAM-1 in the lung vascular endothelium (8). Hence, 
the expression of VCAM-1 in the lung endothelium was com-
pared between PR8-infected and PBS control mice. Indeed, PR8 
infection induced VCAM-1 expression on the lung endothelium 
(Figures 4A,B). VCAM-1 expression was found on the veins, 
arteries, and postcapillary venules in PR8-infected mice. This 
suggests that MCp can be recruited from the blood to the lung 
during influenza infection. To test whether recruitment alone 
could account for the strong increase in lung MCp induced by 
PR8 infection, we took advantage of the CD45.1 strain, which is 
congenic to the wild-type BALB/c (CD45.2) strain. To generate 
BM chimeras, sublethally γ-irradiated CD45.2 BALB/c mice 
were reconstituted with BM cells from CD45.1 congenic mice 
(Figure  5A). We have previously shown that MCp are sensi-
tive to γ-irradiation (9, 19). In line with this observation, lung 
MCp were found to be depleted 2 days after irradiation and BM 
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transfer, i.e., day 0 (Figure 5B). The chimeric mice were infected 
with PR8 or given PBS as control at this time point. The lungs 
of both groups of chimeric mice were analyzed by flow cytom-
etry day 8 post-infection using isoform-specific anti-CD45.1 
and anti-CD45.2 antibodies (Figure S2A in Supplementary 
Material). As expected, the lung MCp from naïve wild-type 
mice were expressing the CD45.2 isoform and the vast majority 
of the lung MCp from PR8-infected or PBS-treated chimeras 
were CD45.1+ cells (Figure  5C). This shows that the lung 
MCp present at day 8 post-infection originate from the donor 
BM cells and that host MCp were still depleted. Thus, in this 
experimental system, the possibility of PR8-induced cell pro-
liferation of host MCp in situ has been prevented. PR8-infected 
chimeras had a significantly higher number of lung MCp per 
mouse compared to naïve non-irradiated CD45.2 mice and 
PBS-treated control chimeras (Figure  5D). Importantly, the 
total number of lung MCp per mouse in chimeric mice 8 days 
post-infection were similar to the total number of lung MCp 
in normal non-irradiated mice at the same day post-infection 
(3,056 ± 264 in Figure 5D vs. 3,739 ± 489 in Figure 2D). This 
indicates that PR8 stimulates an influx of MCp to the lung, to a 
similar extent as in non-irradiated PR8-infected mice. Thus, the 
data strongly suggest that recruitment of MCp from the blood 
to the lung is the major mechanism behind the PR8-induced 
increase in lung MCp. Moreover, PR8-infected chimeras had 
a significantly higher number of lung MNC per mouse and 
frequency of lung MCp compared to naïve non-irradiated 
CD45.2 mice and PBS-treated control chimeras (Figures S2B,C 
in Supplementary Material).
Altogether, the PR8-induced upregulation of VCAM-1 
expression on the lung vascular endothelium and the capacity of 
PR8 to stimulate a similar number of lung MCp in the chimeric 
mice and in normal non-irradiated mice strongly suggest that the 
major mechanism behind the influenza-induced increase in MCp 
numbers is recruitment of blood MCp to the lung.
a Fraction of the recruited Mcp Develops 
into Mc, but the Majority of These Mcs 
are lost when the influenza-induced 
inflammation resolves
To address whether the MCp recruited to the lung upon influenza 
infection are maturing into MCs, a different lung cell isolation 
method to analyze all lung MC populations was set up. In these 
experiments, the cells released after mechanical and enzymatic 
digestion of whole lungs were only purified by removal of debris 
and lysis of red blood cells. Using flow cytometry, the CD45+ 
Lin−/lo c-kithi T1/ST2+ FcεRI+ cells were gated for expression of 
integrin β7 and CD16/32 to analyze all forms of lung MCs. In 
mice given PBS as a control, two major CD45+ Lin−/lo c-kithi T1/
ST2+ FcεRI+ MC populations could be identified (Figure  6A). 
One cell population expressed high levels of integrin β7 and had 
a low mean SSC, which corresponds to the lung MCp population 
(Figures 6A,B, dark blue). The second cell population lacked or 
was expressing low levels of integrin β7 and had a high mean SSC 
profile, which are properties unique to the mature MC population 
in the lung (Figures 6A,B, light blue). However, at days 15 and 
21 post-infection, three MC populations were identified. Besides 
the MCp and the mature MC population, a cell population with 
intermediate expression of integrin β7 could be found (Figure 6A, 
red). This immature MC population had a mean SSC that were 
in between the mature MCs and the lung MCp (Figure 6B). At 
day 15 post-infection, the MCp population was still the dominant 
MC type in the lung, whereas the immature MC population was 
the most frequent of the three MC types at day 21 post-infection 
(Figures 6C,D). Although there was a reduction in the total num-
ber of MCs per mouse lung day 21 compared with day 15 post-
infection, the numbers were still higher than in the mice given 
PBS as a control (Figure 6D). The number of immature MCs was 
increased at day 21 as compared to day 15 post-infection, while 
the number of lung MCp per mouse was reduced (Figure 6D). In 
addition, there were more mature MCs in the lung day 21 than 
day 15 post-infection or in comparison to mice given PBS as a 
control (Figure 6D).
Histological analyses were performed to investigate in which 
locations the influenza-induced MCs accumulate. We found 
that both the PR8-induced inflammation and MC accumulation 
were mainly localized to the central upper airways (Figure 6H). 
This location is consistent with the localization of influenza 
infection, which begins in the large conducting airways later 
spreading to the bronchioles and deeper areas of the lung (25). 
The number of toluidine blue+ MCs in this area of the lungs 
were quantified by manual counting under the microscope in a 
blinded fashion. In mice given PBS, there was no inflammatory 
cell infiltrates around bronchioles or blood vessels (Figure 6E). 
However, 15 days post-infection with PR8, most Br in the upper 
airways were surrounded with inflammatory cells and often 
these inflamed bronchioles contained toluidine blue+ MCs 
(Figure  6E). In fact, there were significantly more toluidine 
blue+ MCs in these locations in the lung at 15 days post-infection 
than in control mice given PBS (Figure 6F). At this time point, 
interstitial MCs in the perivascular space (Figure  6G, panel 
I), in the endothelium (II) or just under the endothelium (III) 
and intra- or sub-epithelial MCs (IV) were also detected in the 
PR8-infected lungs. Interestingly, although the number of lung 
MCs was still significantly higher in PR8-infected mice than 
in PBS-treated mice when analyzed by flow cytometry day 21 
post-infection (Figure 6D), histological analysis demonstrated 
similar numbers of toluidine blue+ MCs in the upper airways of 
PR8-infected and PBS control mice (Figure 6F).
Altogether, these data suggest that PR8 infection induces 
MC accumulation in the lung, which is present as long as the 
inflammation is ongoing. However, most MCs that originate from 
recruited MCp are lost when the inflammation is resolved.
DiscUssiOn
Although earlier studies have shown that MCp are recruited to 
the lung and give rise to MCs in mouse models of allergic airway 
inflammation (8, 9, 12, 13), the present study demonstrates for the 
first time that MCp are recruited to the lung during a completely 
different type of inflammatory response, i.e., influenza infection. 
The H1N1 influenza A virus triggered a tremendous increase 
in highly proliferating lung MCp, which was significant already 
FigUre 6 | Pr8 infection induces a transient accumulation of lung Mcs. (a) Representative dot plots of lung mast cell populations from PR8-infected or PBS 
control mice analyzed at indicated time points post-infection. Three CD45+ Lin−/lo c-kithi T1/ST2+ FcεRI+ populations are distinguished based on their integrin β7 
surface expression in lungs from PR8-infected mice. The gates to identify the MCp and mature MCs were first set according to the two major MC populations 
detected in the lungs from PBS control mice in each individual experiment. Subsequently, a third gate was set for the MCs expressing intermediate levels of integrin 
β7 at each indicated time point after PR8 infection. (a–D) MCp (integrin β7hi; dark blue), immature MCs (integrin β7int; red), and mature MC (integrin β7−/lo; light blue). 
(B) Representative contour plot showing the side scatter (SSC) profile of the three different lung MC populations at day 21 post-infection. The numbers in color 
show the average of the mean SSC for each MC population from all experiments. (c) The frequency (MC/106 lung cells) and (D) the total number of lung MC in PBS 
control mice and from PR8-infected mice at the indicated days post-infection. The proportion of each MC sub-population is distinguished by the corresponding 
color. The graphs in panels (c,D) show data from 8–12 individual mice per group pooled from 2 experiments at day 15, 3 experiments at day 21, and from all 5 
experiments for PBS controls. Black stars show the statistical difference between groups for the sum of all lung MC populations. The light blue stars represent the 
level of significance for the mature MC population. The red stars represent the level of significance for the immature MC population. The dark blue stars represent 
the level of significance for MCp (*P < 0.05, **P < 0.01, ***P < 0.001). (e) Representative images of toluidine blue-stained sections from mice given PBS as a control 
and PR8-infected mice 15 days post-infection. The majority of MCs were found in the upper lobes in the central airways surrounding Bv and Br in the same region 
that contain other infiltrating immune cells. The pink arrows indicate MC. Br, bronchioles; Bv, blood vessels. (F) MC counts per lung section in the central airways. 
The graph represents pooled data from three independent experiments with 6–8 mice per group (*P < 0.05, **P < 0.01). (g) Representative images of toluidine 
blue-stained sections from PR8-infected mice 15 days post-infection divided into I–IV for illustrating where MCs are uniquely located after PR8 infection. (I) MCs 
were frequently found in the central airways in the perivascular region. (II) MCs were also found close to or within the endothelium. (III) MC in the sub-mucosal region. 
(IV) Intraepithelial and sub-mucosal MC. Pink arrows indicate MC. Br, bronchioles; Bv, blood vessels. (h) Graphical representation of the MC localization in the lung 
in PR8-infected mice day 15 post-infection. MCs are represented in blue and other cells/inflammation in red.
9
Zarnegar et al. Accumulation of MCs in Influenza Infection
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 310
4 days post-infection and continued to increase over time during 
the acute phase. However, as lung leukocytes contain a significant 
proportion of intravascular cells that cannot be removed by per-
fusion of the lungs (26), some of the lung MCp that we quantify 
may be trapped in the lung vasculature.
Fifteen days post-infection, the majority of the CD45+  
Lin−/lo c-kithi T1/ST2+ FcεRI+ cells in the lung were still MCp. At 
this time point, an immature MC population that expressed an 
intermediate level of integrin β7 and had an intermediate SSC 
profile was also detected. In line with this finding, a similar transi-
tional MC population was demonstrated before the appearance of 
induced mature MCs in a model of allergic pulmonary inflamma-
tion (13). Therefore, both influenza infection and allergic inflam-
mation trigger a strong influx of MCp to the lung and stimulate 
the maturation of MCp via a similar transitional maturation step. 
However, in our study, the mature MC population, expressing 
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none or low levels of integrin β7, was equally rare as in PBS 
control mice 15 days post-infection. At this time point, increased 
numbers of toluidine blue+ MCs could be found close to the 
inflamed bronchioles in the upper and central airways. Toluidine 
blue+ lung MCs could also be detected in perivascular spaces and 
close to or in the endothelial or epithelial barriers in the PR8-
infected mice. MCs are rarely detected among the inflammatory 
foci in mouse models of allergic airway inflammation but instead 
accumulate in the lung epithelium (9, 27), close to the airway 
smooth muscles (28) and in the alveolar parenchyma (12). Hence, 
our data suggest that the influenza infection in mice triggers lung 
MCs to accumulate at partly different locations than in allergic 
airway inflammation.
The increase in lung MCp upon influenza infection could 
theoretically be due to virus-induced increase in cell prolifera-
tion of lung MCp in  situ, or to the recruitment of MCp to the 
lung via the blood. Our data suggest that lung MCp from naïve 
and influenza-infected lungs are in an equally high proliferative 
state because more than half of the MCp were positive for the cell 
proliferation marker Ki-67 or had incorporated BrdU. The high 
proliferative state of the rare MCp in naive mice is likely required 
to sustain the replacement of the constitutive MC pool in the lung. 
Interestingly, the BrdU+ lung MCp from the PR8-infected mice 
had a lower gMFI than those from mice given PBS. We speculate 
that the higher gMFI in the PBS control mice reflects that most 
(if not all) lung MCp were resident at the time point when BrdU 
was given, whereas in the PR8-infected mice, many MCp were 
recruited between days 7 and 8, and therefore, the gMFI of BrdU+ 
lung MCp is lower. Nevertheless, the equally high proportion 
of Ki-67+ or BrdU+ lung MCp in naïve and PR8-infected mice 
implies that recruitment would be the major mechanism behind 
the influenza-induced increase in the number of lung MCp. To test 
this, CD45.2 mice depleted of lung MCp and reconstituted with 
BM cells from congenic CD45.1 donors were instilled intranasally 
with PBS or infected with PR8. This experimental system allowed 
us to test whether the strong increase in lung MCp induced by 
influenza infection could be due to recruitment alone since the 
host lung MCp were depleted from the lung before infection and 
remained so until the day of analysis. The PR8 infection induced 
a stronger influx of MCp to the lung than the PBS treatment alone 
in the chimeric mice. Importantly, the high number of lung MCp 
(of donor origin) in the PR8-infected chimeric mice was similar 
to the total number of lung MCp induced by PR8 infection in 
normal mice. Therefore, these experiments clearly show that the 
increase in MCp upon PR8 infection could be explained entirely 
by the recruitment of MCp from the blood to the lung. However, 
the results from the irradiation and transfer experiments need 
to be interpreted with caution since injection of whole BM cells 
into the blood circulation leads to an artificial presence of all 
types of hematopoietic progenitor cells in the circulation, and 
the irradiation may cause increased vascular permeability in the 
lung (29, 30). Importantly, PR8 infection significantly enhanced 
the expression of VCAM-1 on the lung endothelium. Since we 
previously showed that MCp were recruited to the lung in a 
VCAM-1-dependent fashion in a mouse model of allergic airway 
inflammation (8), the induced VCAM-1 expression suggests 
that MCp use the same transmigration mechanism in influenza 
infection and allergic airway inflammation. Altogether, we con-
clude that influenza infection triggers the recruitment of MCp, 
which are in a high proliferative state, to the lung.
Three weeks post-influenza infection when most of the lung 
inflammation was resolved, the total sum of the individual 
lung MC populations was reduced by 50% compared to day 15, 
although the total sum of MCs in different developmental stages 
were still 4 times higher than in PBS-treated mice. This indicates 
that homeostatic mechanisms also apply to the influenza-induced 
MC populations. At the same time, the number of toluidine 
blue+ cells in the upper airways was similar to the basal levels 
detected in mice given PBS. Although this may seem inconsist-
ent, it is easier to detect differences when MCs are quantified 
by flow cytometry than by histological analysis. Moreover, the 
histological quantifications were performed on the central and 
upper small airways where both the inflammation and the MC 
accumulation were focused, whereas the flow cytometry was 
performed on cells from homogenized whole lungs. Indeed, also 
in mice subjected to an experimental asthma model, the majority 
of the MCs are localized to the central airways (31). Hence, the 
residual influenza-induced MCs detected by flow cytometry at 
day 21 post-infection may be dispersed throughout the lungs, and 
therefore, a difference would not be easily detectable by histology. 
We speculate that the reduction of the influenza-induced MCs 
takes place by Fas-mediated cell death accompanied with local 
phagocytic clearance as described for influenza-induced recruited 
macrophages during the resolution phase of PR8 infection (32). 
Another plausible explanation is that there are too low levels of 
SCF present after the resolution of PR8-induced inflammation to 
sustain the long-term survival of the lung MCs which originate 
from recruited MCp. SCF is the only known crucial factor that is 
truly necessary for survival of tissue MCs in vivo. This is perhaps 
best exemplified by different MC-deficient mouse strains, which 
lack MCs due to loss of a functional receptor for SCF, Kit, e.g., W/
Wv or Wsh/Wsh mice, or lack SCF (KitlSl/KitSl-d mice) (33–35). 
Therefore, the PR8-induced MCs may die through Bim-mediated 
growth factor deprivation-induced apoptosis (36). However, 
determining the precise mechanism behind the loss of influenza-
induced MC accumulation in the lungs was beyond the scope of 
this investigation.
The present study demonstrates the accumulation of MCs 
in the airways in response to a respiratory virus infection in 
mice. However, in other species, increases in MC numbers have 
been observed previously in connection with different types 
of respiratory virus infections. For example, an increased MC 
number was demonstrated in bronchoalveolar lavage fluid and 
in the airway lumen of dogs infected with influenza C virus (37). 
In rats, parainfluenza type 1 virus (Sendai) induced an increase 
in the number of bronchiolar MCs (38). In addition, humans 
naturally infected with cold had increased number of MCs in the 
sub-epithelial layer of the nasal mucosa (39). Thus, the induction 
of increased number of MCs in affected tissues upon respiratory 
virus infections seems to be a general phenomenon and not 
restricted to mice or the PR8 influenza strain.
In human asthma, MC numbers are increased in certain 
locations of the lung, i.e., in the airway smooth muscles and lung 
epithelium (2, 3). However, also the phenotype of MCs present in 
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human asthmatics differs dependent on severity. For example, in 
severe asthmatics, MCs of the tryptase+/chymase+ phenotype are 
most predominant in the airway submucosa and epithelium (40). 
We recently identified a rare human MCp population in blood 
that, similar to its counterpart in murine lung, expresses FcεRI 
and integrin β7 (41). These human MCp are likely the immediate 
precursors to human tissue MCs. Therefore, accumulation of lung 
MCs due to recruitment and maturation of MCp in response to 
virus infections may occur in humans as well.
MCs may play a role in initiating or amplifying the immune 
reactions when activated through pattern recognition recep-
tors during influenza infection (6). For example, both human 
and mouse MCs derived in  vitro become activated in a RIG-
I-dependent fashion upon influenza infection (7). However, 
since MCs presumably cannot directly eliminate viruses or 
virus-infected cells, the participation of MCs for making a pro-
tective host defense against respiratory virus infections is likely 
limited. Instead, MCs may contribute to an excess pathology and 
deteriorating lung function in certain individuals through their 
activation and release of mediators. Altogether, our data in mice 
show that the recruitment of MCp to the lung during influenza 
infections will increase the MC burden at least temporarily over 
a few weeks. We speculate that the accumulation of MCs due to 
respiratory virus infections contributes to the increased symp-
toms seen in patients with asthma that suffer from virus-induced 
exacerbations. In such occasions, MCs and possibly also MCp 
may be activated by IgE/antigen and/or via pattern recognition 
receptors. Moreover, asthma patients, due to the chronic inflam-
mation in their lung, may have sustained production of survival 
factors such as SCF and may thus retain virus-induced accumula-
tions of MCs for a longer time.
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